Published in the prestigious Journal of Cell Biology, the study harnessed the power of model organisms and human cancer cells to dissect the enigmatic role of polyploidy in tumor aggressiveness. Utilizing Drosophila melanogaster (fruit flies) alongside cultured human lung cancer cells, the researchers elucidated how the acquisition of chromosomal excess induces a cellular stress response mediated by the enzyme c-Jun N-terminal kinase (JNK). This kinase, widely known for its role in stress response and apoptosis, surprisingly reprograms polyploid epithelial cells, endowing them with capabilities akin to immune cells: enhanced motility and the ability to engulf neighboring cells.

The mechanistic journey begins with the burden of managing surplus genetic material. Polyploid cells synthesize a surfeit of proteins, overwhelming their proteostatic machinery and generating elevated levels of reactive oxygen species (ROS). This oxidative stress constitutes a molecular signal that triggers JNK activation. The downstream signaling cascade prompts cytoskeletal reorganization and upregulation of genes associated with cell migration and phagocytosis. Consequently, these polyploid cells acquire a remarkable edge in mobility, allowing them to traverse tissue barriers with increased efficacy—a hallmark of metastatic cancer.

Perhaps most striking is the cells’ newfound appetite for their neighbors. The study shows that polyploid cells can actively engulf adjacent cells, a behavior reminiscent of professional phagocytes in the immune system. This cellular cannibalism is thought to confer survival advantages, enabling polyploid cells to scavenge nutrients and outcompete less aggressive tumor clones. Through such mechanisms, polyploidy does not merely confer stress resistance but actively promotes invasive and competitive phenotypes within the tumor microenvironment.

The team’s pivotal findings emerged from elegant experiments wherein JNK signaling was chemically or genetically inhibited. Both fruit fly polyploid cells and human lung cancer cells exhibited a marked reduction in migratory behavior when JNK activity was blocked. This functional reversal underscores the kinase’s central role as a molecular switch driving cellular reprogramming in response to polyploidy-induced stress. Importantly, this suggests that targeting JNK or related stress pathways could become a viable therapeutic strategy to stymie tumor progression.

Tulane’s professor and corresponding author, Wu-Min Deng, underscores the translational significance of the findings. “Our data suggest that elevated reactive oxygen species and JNK activation may underlie the enhanced motility of polyploid cancer cells. Targeting stress-sensing pathways in polyploid cells could therefore represent a new therapeutic strategy to limit tumor invasion.” This perspective shifts the research focus onto cellular stress responses as targets, an area that has been underappreciated in the context of polyploidy-driven malignancy.

While polyploidy is often demonized in cancer biology, it is imperative to recognize its dualistic nature. In healthy tissues such as the heart and liver, polyploid cells are physiological and beneficial, augmenting regenerative capacity and tissue repair. These cells leverage their expanded genomic content to amplify protein production and support tissue homeostasis where stem cell pools are limited. Thus, polyploidy presents a double-edged sword: indispensable for regeneration yet potentially disastrous when hijacked by cancer cells.

Co-first author Youfang Zhou highlights this paradoxical biology, noting that “the same internal stress that helps polyploid cells survive may also make them more mobile and give them a competitive advantage.” This intrinsic stress response, initially a protective adaptation, becomes a driver of malignancy through enhancement of invasive traits and cellular aggressiveness. It reveals the nuanced interplay between cellular survival mechanisms and cancer progression.

Adding further depth, co-first author Xianfeng Wang describes induced polyploid cells as “not only stress resistant but also actively responsive, engaging in behaviors typically associated with immune or invasive cells.” This points to a remarkable cellular plasticity—polyploid cells integrate stress signals to acquire dynamic functionalities that empower them within the tumor microenvironment. Such adaptability likely contributes to the therapy resistance observed in aggressive cancers enriched with polyploid populations.

The implications for cancer therapy are profound. Standard treatments often fail against polyploid tumor cells due to their enhanced survival and invasive capabilities. By elucidating the molecular axis of ROS production, JNK activation, and subsequent motility and phagocytosis, this research opens new avenues for precision medicine. Therapeutic strategies aimed at disrupting stress-sensing pathways and inhibiting JNK could suppress the metastatic potential of polyploid cancer cells and improve patient outcomes.

Furthermore, the interdisciplinary approach combining model organism genetics with human cancer cell biology exemplifies the innovative methodologies required in contemporary cancer research. This cross-species validation reinforces the conserved nature of the stress signaling mechanisms, bolstering confidence in therapeutic targeting across diverse cancer types.

In closing, this seminal work from Tulane University represents a paradigm shift in understanding how polyploidy confers malignant advantages at the cellular level. By transforming stress into a signal that rewires epithelial cell behavior, polyploid cancer cells become formidable agents of invasion and resistance, helping explain the clinical challenge posed by aggressive tumors. Targeting the JNK-mediated stress response pathway promises a potentially transformative strategy to curb tumor spread and improve therapeutic efficacy.

Subject of Research: Polyploid cancer cells and their role in tumor aggressiveness and invasion via stress signaling pathways.

Article Title: Polyploidy reprograms epithelial cells for motility and phagocytosis via stress signaling

Web References:

• Journal of Cell Biology article: https://rupress.org/jcb/article/225/5/e202507096/281804/Polyploidy-reprograms-epithelial-cells-for?guestAccessKey=
• DOI link: http://dx.doi.org/10.1083/jcb.202507096

Keywords: Polyploid cancer cells, tumor invasion, cellular stress response, JNK signaling, reactive oxygen species, cancer metastasis, epithelial cell motility, cell cannibalism, therapy resistance, cancer cell plasticity, lung cancer, Drosophila model

Typically, animal cells maintain a diploid state with two sets of chromosomes, one inherited maternally and the other paternally. However, polyploidy emerges when cells either duplicate their genome in preparation for division but fail to undergo cytokinesis, or develop through alternative mechanisms. While polyploidy can serve essential physiological roles—such as enabling liver cells to enlarge and adapt to metabolic demands—it is increasingly recognized as a driver in malignancy, endowing cancer cells with heightened resistance to environmental stresses, therapeutic interventions, and enhanced proliferative capacity.

Led by Professor Wu-Min Deng, the Tulane research team employed Drosophila melanogaster larvae as an experimental model to elucidate the consequences of polyploidy on epithelial cell behavior. Through genetic manipulation, they induced polyploidy within these cells and observed a striking phenotypic transformation. Unlike their diploid counterparts, polyploid cells exhibited pronounced migratory aptitude, actively moving through tissues rather than remaining static. Intriguingly, these polyploid cells also engaged in phagocytosis, engulfing neighboring diploid cells, especially those undergoing apoptosis or otherwise compromised in health.

Mechanistically, the study identifies a critical link between increased chromosome content and augmented protein synthesis. The metabolic burden imposed by excess protein production leads to perturbations within the protein folding and synthesis machinery of the cell, resulting in elevated levels of reactive oxygen species (ROS). The accumulation of ROS activates the Jun N-terminal kinase (JNK) signaling pathway, a well-characterized stress response mechanism in cells. This pathway, once engaged, drives cytoskeletal reorganization and transcriptional changes that collectively potentiate cell motility and phagocytic activity.

Importantly, intervention experiments demonstrated that treating fruit flies with antioxidants effectively suppressed ROS accumulation, dampening JNK pathway activation and consequently reducing the migratory and engulfment capabilities of polyploid cells. Similarly, pharmacological inhibition of JNK signaling elicited comparable effects, underscoring the pivotal role of this pathway in reprogramming epithelial cell behavior in response to polyploidy-induced stress.

Expanding the relevance of these findings beyond model organisms, the researchers investigated human lung cancer cells engineered to undergo polyploidization. Consistent with their in vivo observations in Drosophila, polyploid human cancer cells displayed enhanced motility. When treated with antioxidants or JNK inhibitors, these human cells exhibited markedly reduced migration, confirming that the ROS-JNK axis activated by polyploidy is conserved across species and critical in modulating cancer cell dynamics.

This convergence of stress signaling and altered cell phenotype sheds light on why polyploid cancer cells accumulate in particularly aggressive, treatment-resistant tumors. By co-opting the stress response machinery, these cells gain units of advantage: they can invade adjacent tissues by migrating and simultaneously eliminate weaker competing cells through phagocytosis, effectively sculpting the tumor microenvironment to favor their survival and expansion.

The discovery that polyploidy-induced ROS production and JNK activation can be pharmacologically modulated suggests a promising therapeutic avenue. Drugs targeting elements of this stress-sensing axis could potentially inhibit the aggressive traits of polyploid cancer cells, limiting invasion and metastasis without affecting diploid cells that constitute normal tissue architecture. Such selectivity is crucial to minimizing side effects during cancer treatment.

Moreover, the study highlights the intricate interplay between genome duplication, metabolic stress, and cellular signaling pathways. It emphasizes the need for a deeper understanding of how subtle alterations in chromosome number can ripple through molecular networks to induce profound changes in cell behavior. This paradigm shift in cancer biology challenges the classical view of polyploidy solely as a consequence of genomic instability, positioning it instead as an active driver of tumor evolution and malignancy.

The research conducted by Deng et al. also opens new questions about the evolutionary advantages of polyploidy in normal physiology versus pathology. While polyploidy facilitates tissue growth and regeneration under controlled settings, its aberrant manifestation in cancer alters tissue homeostasis detrimentally. Deciphering the molecular switches that discriminate between beneficial and harmful polyploidy outcomes may aid in designing targeted interventions.

In conclusion, this landmark study elucidates how polyploid cells harness oxidative stress and the JNK signaling pathway to gain migratory and phagocytic capabilities, thereby contributing to the invasive potential of tumors. By bridging insights from fruit fly models to human cancer cells, the findings establish a conserved mechanistic framework with significant implications for cancer therapy. Targeting the stress-induced motility program of polyploid cells holds promise for developing strategies to combat aggressive cancers that currently elude effective treatment.

Subject of Research: Animals

Article Title: Polyploidy reprograms epithelial cells for motility and phagocytosis via stress signaling

News Publication Date: 21-Apr-2026

Web References: http://dx.doi.org/10.1083/jcb.202507096

References: Zhou et al., 2026. Journal of Cell Biology

Image Credits: ©2026 Zhou et al. Originally published in Journal of Cell Biology

Keywords: Cancer, Cancer cell phenotypes, Polyploids, Cell biology